Katz, E <br/><br/>
A gene on the HER2 amplicon, C35, is an oncogene in breast cancer whose actions are prevented by inhibition of Syk.  [electronic resource] 

 -  British journal of cancer  Jul 2010 
 - 401-10 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1532-1827 
<br/><br/><label>Standard No.: </label>10.1038/sj.bjc.6605763  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antibodies, Monoclonal--therapeutic use<br/>Antibodies, Monoclonal, Humanized<br/>Antigens, CD<br/>Breast Neoplasms--drug therapy<br/>Cadherins--genetics<br/>Cell Line, Tumor<br/>Colony-Forming Units Assay<br/>DNA Primers<br/>Down-Regulation<br/>Female<br/>Gene Amplification<br/>Genes, erbB-2<br/>Humans<br/>Immunohistochemistry<br/>Intracellular Signaling Peptides and Proteins--antagonists & inhibitors<br/>Neoplasm Proteins--genetics<br/>Oligonucleotide Array Sequence Analysis<br/>Open Reading Frames<br/>Protein-Tyrosine Kinases--antagonists & inhibitors<br/>RNA, Messenger--genetics<br/>Receptor, ErbB-2--antagonists & inhibitors<br/>Reverse Transcriptase Polymerase Chain Reaction<br/>Syk Kinase<br/>Transfection<br/>Trastuzumab